Frontlight ResearchEarly access
Trial site
Qinghai Red Cross Hospital
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Cervical cancer1 trial
- Coronary artery disease1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Hepatitis B1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Phase
- Phase 32 trials
- Phase 41 trial
- Status
- Recruiting3 trials
- Not yet recruiting2 trials
- Completed1 trial
- Lead sponsor
- Qinghai Red Cross Hospital2 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Peking University First Hospital1 trial
- Qilu Hospital of Shandong University1 trial
- Zhujiang Hospital1 trial
Running trials
Not yet recruiting
Recruiting
Not yet recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
Recruiting
Recruiting
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Hepatitis B1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026